Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06417814
PHASE3

A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Sponsor: AstraZeneca

View on ClinicalTrials.gov

Summary

This study will assess the effect of Dato-DXd in combination with osimertinib or Dato-DXd monotherapy versus platinum-based doublet chemotherapy in terms of progression-free survival (PFS).

Official title: A Phase III, Open-label, Sponsor-blind, Randomized Study of Dato-DXd With or Without Osimertinib Versus Platinum-based Doublet Chemotherapy for Participants With EGFR-mutated Locally Advanced or Metastatic Non-small Cell Lung Cancer Whose Disease Has Progressed on Prior Osimertinib Treatment (TROPION-Lung15)

Key Details

Gender

All

Age Range

18 Years - 130 Years

Study Type

INTERVENTIONAL

Enrollment

768

Start Date

2024-10-04

Completion Date

2028-09-27

Last Updated

2026-10-15

Healthy Volunteers

No

Interventions

DRUG

Dato-DXd

Dato-DXd will be administered as IV infusion.

DRUG

Osimertinib

Osimertinib will be administered orally.

DRUG

Pemetrexed

Pemetrexed will be administered as IV infusion.

DRUG

Carboplatin

Carboplatin will be administered as IV infusion.

DRUG

Cisplatin

Cisplatin will be administered as IV infusion.

Locations (211)

Research Site

Fayetteville, Arkansas, United States

Research Site

Fountain Valley, California, United States

Research Site

San Diego, California, United States

Research Site

Jacksonville, Florida, United States

Research Site

Kansas City, Missouri, United States

Research Site

New York, New York, United States

Research Site

Maumee, Ohio, United States

Research Site

Pittsburgh, Pennsylvania, United States

Research Site

Nashville, Tennessee, United States

Research Site

Fitzroy, Australia

Research Site

Heidelberg, Australia

Research Site

Kogarah, Australia

Research Site

Liverpool, Australia

Research Site

Nedlands, Australia

Research Site

St Leonards, Australia

Research Site

Westmead, Australia

Research Site

Woolloongabba, Australia

Research Site

Charleroi, Belgium

Research Site

Edegem, Belgium

Research Site

Ghent, Belgium

Research Site

Hasselt, Belgium

Research Site

Jette, Belgium

Research Site

Namur, Belgium

Research Site

Roeselare, Belgium

Research Site

Barretos, Brazil

Research Site

Betim, Brazil

Research Site

Porto Alegre, Brazil

Research Site

Porto Alegre, Brazil

Research Site

Rio de Janeiro, Brazil

Research Site

Rio de Janeiro, Brazil

Research Site

Rio de Janeiro, Brazil

Research Site

São Paulo, Brazil

Research Site

Brampton, Ontario, Canada

Research Site

Toronto, Ontario, Canada

Research Site

Toronto, Ontario, Canada

Research Site

Montreal, Quebec, Canada

Research Site

Québec, Quebec, Canada

Research Site

Baoding, China

Research Site

Beijing, China

Research Site

Beijing, China

Research Site

Beijing, China

Research Site

Beijing, China

Research Site

Beijing, China

Research Site

Beijing, China

Research Site

Bengbu, China

Research Site

Changchun, China

Research Site

Changsha, China

Research Site

Chengdu, China

Research Site

Deyang, China

Research Site

Ganzhou, China

Research Site

Guangzhou, China

Research Site

Hangzhou, China

Research Site

Hangzhou, China

Research Site

Hefei, China

Research Site

Hengyang, China

Research Site

Jinan, China

Research Site

Linyi, China

Research Site

Luoyang, China

Research Site

Luzhou, China

Research Site

Nanchang, China

Research Site

Nanjing, China

Research Site

Shanghai, China

Research Site

Shantou, China

Research Site

Shenyang, China

Research Site

Shenyang, China

Research Site

Tianjin, China

Research Site

Weifang, China

Research Site

Wuhan, China

Research Site

Zhengzhou, China

Research Site

Zhengzhou, China

Research Site

Zhengzhou, China

Research Site

Bordeaux, France

Research Site

Caen, France

Research Site

Lille, France

Research Site

Montpellier, France

Research Site

Nantes, France

Research Site

Paris, France

Research Site

Pessac, France

Research Site

Toulon Armees, France

Research Site

Toulouse, France

Research Site

Villejuif, France

Research Site

Berlin-Zehlendorf, Germany

Research Site

Essen, Germany

Research Site

Georgsmarienhütte, Germany

Research Site

Großhansdorf, Germany

Research Site

Hamburg, Germany

Research Site

Hamburg, Germany

Research Site

Löwenstein, Germany

Research Site

Nuremberg, Germany

Research Site

Athens, Greece

Research Site

Athens, Greece

Research Site

Thessaloniki, Greece

Research Site

Thessaloniki, Greece

Research Site

Thessaloniki, Greece

Research Site

Hong Kong, Hong Kong

Research Site

Hong Kong, Hong Kong

Research Site

Hyderabad, India

Research Site

Kolhāpur, India

Research Site

Mumbai, India

Research Site

Namakkal, India

And 111 more locations on ClinicalTrials.gov